spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Verastem 

 HSMN NewsFeed - 11 Apr 2024
Orna Therapeutics Appoints Frank Neumann, M.D., Ph.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Nov 2020
Elevation Oncology Announces $65M Series B Financing and Promotion of Founder Shawn M. Leland to Chief Executive Officer
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 2 Nov 2016
Verastem Licenses Duvelisib from Infinity Pharmaceuticals
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 15 Mar 2016
CoLucid Pharmaceuticals Announces Election of Alison Lawton to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Dec 2014
Verastem Appoints Daniel Paterson as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 Oct 2014
Allied-Bristol Life Sciences Appoints Former Bristol-Myers Vice President Satish Jindal to Lead the Discovery of Drug Candidates From Leading Academic Institutions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 May 2014
Lightstone Ventures Closes First Fund at $172 Million
Venture Capital
 HSMN NewsFeed - 24 Jul 2013
Verastem Receives Orphan Drug Designation from the U.S. FDA for Defactinib in Mesothelioma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 6 Jun 2013
Verastem Appoints Robert Forrester as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 30 Apr 2013
Henri A. Termeer Joins Moderna Therapeutics Board Of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Feb 2013
Verastem Files for Orphan Disease Status for VS-6063 in Mesothelioma
Biopharmaceuticals Oncology Regulatory FDA
 HSMN NewsFeed - 22 Jan 2013
Verastem Promotes Chief Operating Officer Robert Forrester to President
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 19 Sep 2012
Louise Phanstiel Joins Verastem Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Jul 2011
Verastem Raises $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 May 2011
Verastem, Inc. Appoints Robert Forrester as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Nov 2010
Verastem Secures $16 Million in Series A Financing for Novel Cancer Stem Cell Drugs
Biopharmaceuticals Oncology Venture Capital
Return to NewsFeed  
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.